Bostwick, D. G., Wilk, M. M., Bostwick, B. R., Rydesky, P. M., Littrup, P. J., Cribbs, M., . . . Qian, J. (2023). 706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial). BMJ Publishing Group.
Cita Chicago (17th ed.)Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.
Cita MLA (9th ed.)Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.